NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
59 hedge funds and large institutions have $13.3M invested in Nymox Pharmaceutical Corp in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $14.2M → $13.3M (-$924K)
Holders
59
Holding in Top 10
–
Calls
$45K
Puts
$13K
Top Buyers
| 1 | +$505K | |
| 2 | +$167K | |
| 3 | +$133K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$133K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.6K |
Top Sellers
| 1 | -$168K | |
| 2 | -$94.8K | |
| 3 | -$76.2K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$65.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$54.3K |